Pfizer India speaks up after Karnataka FDA crackdown, says patient safety is top priority
Pfizer India has stated that patient safety and product quality are their top priorities following FDA actions. The Karnataka FDA canceled 16 drug licenses and suspended eight others due to counterfeit drugs. A raid uncovered an illegal operation repacking low-cost medicines as branded drugs, particularly Pfizer products. Pfizer has removed affected batches from the market and is cooperating with authorities in the investigation.
RSS News
Economic times
0 thoughts on “Pfizer India speaks up after Karnataka FDA crackdown, says patient safety is top priority”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- ‘Uncle’ George Clooney lends support for Cindy Crawford after Presley Gerber’s passing
- Rajpal Yadav opts for public queue at Lalbaugcha Raja for darshan
- Pfizer India speaks up after Karnataka FDA crackdown, says patient safety is top priority
- Actress Savithri Sreedharan passes away
- Karnataka launches action plan to cut salt intake by 30% by 2030
